Octave Bioscience’s MSDA Test Demonstrates Clinically Actionable Insights for Improved MS Care Decisions
Octave Bioscience’s MSDA Test Demonstrates Clinically Actionable Insights for Improved MS Care Decisions In a significant advancement for the field of neurodegenerative disease management, Octave Bioscience, Inc., a precision care…
ACIP Backs Pfizer’s RSV Vaccine ABRYSVO for At-Risk Adults Aged 50–59
ACIP Backs Pfizer’s RSV Vaccine ABRYSVO for At-Risk Adults Aged 50–59 Pfizer Inc. (NYSE: PFE) has taken a significant step forward in the effort to combat respiratory syncytial virus (RSV)…
GSK’s 5-in-1 Meningitis Vaccine PENMENVY Backed by U.S. Advisory Panel
GSK’s 5-in-1 Meningitis Vaccine PENMENVY Backed by U.S. Advisory Panel In a pivotal step forward for meningococcal disease prevention in the United States, GSK plc announced that the Advisory Committee…
eGenesis and OrganOx Secure U.S. FDA IND Clearance for Acute-On-Chronic Liver Failure Treatment
eGenesis and OrganOx Secure U.S. FDA IND Clearance for Acute-On-Chronic Liver Failure Treatment eGenesis, a pioneering biotechnology company focused on developing human-compatible engineered organs, and OrganOx Ltd., a leading medical…
ImmunityBio Files Supplemental BLA for NMIBC and Expands ANKTIVA Access for Lymphopenia Treatment
ImmunityBio Files Supplemental BLA for NMIBC and Expands ANKTIVA Access for Lymphopenia Treatment ImmunityBio, Inc. (NASDAQ: IBRX), a leading company specializing in immunotherapy, has recently made significant strides in advancing…
Tivic Health Expands Global License for TLR5 Agonist Entolimod to Include Neutropenia Treatment
Tivic Health Expands Global License for TLR5 Agonist Entolimod to Include Neutropenia Treatment Tivic Health Systems, Inc. , a diversified therapeutics company focused on advancing innovative treatment solutions, has made…
Scipher Medicine and Kythera Labs Join Forces to Advance Autoimmune Disease Treatment
Scipher Medicine and Kythera Labs Join Forces to Advance Autoimmune Disease Treatment In a groundbreaking move aimed at advancing precision medicine in the realm of autoimmune diseases, Scipher Medicine, a…
Click Therapeutics Secures FDA Approval for First-Ever Prescription Digital Migraine Therapy
Click Therapeutics Secures FDA Approval for First-Ever Prescription Digital Migraine Therapy In a significant milestone for digital health and the millions of people affected by migraine disorders, Click Therapeutics, Inc.…
n-Lorem Foundation Celebrates Five Years of Innovation for Nano-Rare Diseases
n-Lorem Foundation Celebrates Five Years of Innovation for Nano-Rare Diseases In an era where access to highly specialized medical treatments is often hindered by costs, timelines, and logistical constraints, the…
Eyestem’s Eyecyte-RPE™ Demonstrates Vision Preservation in Geographic Atrophy Clinical Trial
Eyestem’s Eyecyte-RPE™ Demonstrates Vision Preservation in Geographic Atrophy Clinical Trial Bangalore-based biotech firm Eyestem Research has reported highly encouraging results from its Phase 1 clinical trial evaluating Eyecyte-RPE™, a novel…
Atelerix Partners with MineBio to Distribute Cell Preservation Solutions in China
Atelerix Partners with MineBio to Distribute Cell Preservation Solutions in China UK-based biotech innovator Atelerix partners with MineBio to bring next-generation ambient-temperature cell preservation to the world’s fastest-growing biopharma market.…
Nuclera Enhances eProtein Platform to Support Membrane Protein Production
Nuclera Enhances eProtein Platform to Support Membrane Protein Production Nuclera, a leading biotechnology innovator specializing in rapid protein expression and optimization, today announced a significant enhancement to its flagship benchtop…